المؤلفون: Hee H. Ho, Heerajnarain Bulluck, Philip Wong, Boon Wah Liew, Gao Fei, Ashish Chawla, Aaron Sung Lung Wong, Terrance Chua, Yiu-Cho Chung, Chi-Hang Lee, Lynette Teo, Jack Wei Chieh Tan, Patrick Lim Zhan Yun, Mark Y. Chan, Marcus Ong Eng Hock, Mervyn H. H. Chan, Evelyn Wong, Ping Chai, Swee Han Lim, Andrew John Hoe, Valeria Paradies, Derek J. Hausenloy, Matthew T. Roe, Andrew Fu Wah Ho, Timothy Watson, Syed Saqib Imran, Jennifer Bryant

المصدر: Clinical Cardiology. 42:5-12

مصطلحات موضوعية: Male, medicine.medical_treatment, 030204 cardiovascular system & hematology, law.invention, chemistry.chemical_compound, 0302 clinical medicine, Bolus (medicine), P2Y12, Randomized controlled trial, law, 030212 general & internal medicine, Myocardial infarction, Infusions, Intravenous, Aged, 80 and over, Ventricular Remodeling, General Medicine, Middle Aged, Treatment Outcome, Cardiology, Female, Cardiology and Cardiovascular Medicine, Adult, medicine.medical_specialty, Trial Designs, Magnetic Resonance Imaging, Cine, Myocardial Reperfusion, Myocardial Reperfusion Injury, Young Adult, 03 medical and health sciences, Percutaneous Coronary Intervention, Cangrelor, Double-Blind Method, Coronary Circulation, Internal medicine, medicine, Humans, cardiovascular diseases, Ventricular remodeling, Aged, business.industry, Myocardium, Percutaneous coronary intervention, medicine.disease, Adenosine Monophosphate, chemistry, ST Elevation Myocardial Infarction, business, Reperfusion injury, Platelet Aggregation Inhibitors, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f0160e028bef172d0e4bd9a936ca327
https://doi.org/10.1002/clc.23110